Full Breakdown
Palantir’s NHS Data Platform Faces Growing Public Backlash and Government Review
9/7/2026, 11:42:55 PM
Rising Patient Opt-Outs Threaten Data-Driven Care Plans
In the two-month period from mid-May to mid-July, an additional 60,000 people used the national data opt-out to withdraw their private health information from research and planning uses. The surge follows heightened media focus on Palantir Technologies, the U.S. defence and health-tech firm that runs the NHS’s federated data platform (FDP) under a £330 million, seven-year contract. Doctors and patient groups warn that such withdrawals could undermine the NHS’s long-term efficiency goals.
Government Assessment of the Palantir Contract
Health Innovation Minister James Frith has expressed concern that “mistrust” of Palantir may affect willingness to share data. He told Commons health committee chair Layla Moran that the rise in opt-outs was “modest” but would be monitored. Frith also warned that “it may not be possible to realise the benefits of the 10-year health plan if patients stop sharing their data” “It may not be possible to realise the benefits of the 10-year health plan if patients stop sharing their data.” — James Frith, the health innovation minister. The government is weighing whether to invoke a break clause in Palantir’s contract, a move urged by several doctors’ and patients’ organisations.
Claims of Clinical Impact and Their Limits
Palantir’s spokesperson claims the AI-driven platform has helped NHS trusts record 110,000 additional operations, achieve a 15 % reduction in discharge delays for long-stay patients, and improve the proportion of cancer diagnoses communicated within 28 days by 6.8 %. The statistics watchdog is currently investigating the data.
Prospects for the FDP and NHS Data Sharing
The health ministry has indicated that there is no longer a requirement for trusts to use the FDP, opening the possibility of an alternative provider. Ministers have been urged to act promptly, as a prolonged transition could delay the delivery of the NHS’s 10-year health plan. The outcome of the contract review will shape how patient data is leveraged for research and service improvement across England.
